Home » Combination of Gilead, Bristol-Myers Hepatitis C Drugs Show Promise in Study
Combination of Gilead, Bristol-Myers Hepatitis C Drugs Show Promise in Study
A regimen combining experimental drugs from Gilead Sciences and Bristol-Myers Squibb suppressed the hepatitis C virus in most patients four weeks after completing treatment, according to a new study.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
07May
-
14May
-
30May